Effectiveness of early alpha-interferon therapy for hepatitis C virus infection recurrence after liver transplantation.
The results in this short series show that early and prolonged alpha-interferon therapy for hepatitis C virus recurrence after liver transplantation could bring some benefit to the infected liver grafts. The risk of graft rejection was clearly minimised by maintaining immunosuppression at normal levels.
Boillot
O
O
Unité de Transplantation Hépatique, Fédération des Spécialités Digestives, hôpital Edouard Herriot, Lyon, France.
Berger
F
F
Rasolofo
E
E
Mion
F
F
Chevallier
P
P
Gille
D
D
Paliard
P
P
D006526:Hepatitis C / Q000628:therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D016031:Liver Transplantation; D012008:Recurrence
D016898:Interferon-alpha